Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Am J Surg Pathol. 2020 Mar;44(3):368–377. doi: 10.1097/PAS.0000000000001382

Table 1.

Sclerosing Epithelioid Fibrosarcoma with YAP1 and/or KMT2A rearrangements

Age/Sex Location (depth) Size (cm) Mitotic count (10HPF) Genetics Follow-up
RNAseq & RT-PCR (exon number) YAP1 FISH KMT2A FISH
1 45/F Paraspinal (deep) 2.6 P: 0
R1: 1
YAP1(5)-KMT2A(4)# NEG (1X) NEG Recur (1yr)
2 45/F Thigh (subcutis) 3.4 P:17
Mets: 21
YAP1(4)-KMT2A(5)# NEG (1X) NEG Mets to soft tissue (1.5yr)
3 47/M Lower leg (deep) 2.0 P: NA
R1: 5
R2: 0
R3: 2
YAP1(5)-KMT2A(4)# POS NEG Recur (10, 17, 21 yr)
4 73/F Iliopsoas muscle (deep) 10 8 ND NEG (1X) POS DOD (1yr), mets to contralateral pelvis & scalp
5 35/M Chest wall (deep) 5.0 3 ND NEG POS* Recent
6 10/F Frontal dura (deep) 12 9 ND NEG POS NED (2.5yr)
7 86/M Inguinal (NA) NA 11 ND POS NEG NA
8 42/M Thigh (subcutis) 2.5 4 YAP1(5)-KMT2A(4) NEG NEG Recent
9 22/M Neck/paraspinal (deep) 8 4 KMT2A(6)-YAP1(9) NEG (1X) NEG (1X) AWD (1yr)
*

MAML2 FISH also positive for rearrangement

#

RNAseq

RT-PCR, (parenthesis are exonic breakpoint)

MSK-IMPACT; F, female; HPF, high power fields; M, male; mets, metastasis; NA, not available; ND, not done; NEG, negative; P, primary tumor; POS, positive; R1, first recurrence; R2, second recurrence; R3, third recurrence; RNAseq, RNA sequencing; RT-PCR, reverse transcription polymerase chain reaction; yr, year(s); 1X, only one copy of fused signals.